Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2000
08/10/2000WO2000046235A1 Novel betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors
08/10/2000WO2000046228A2 Pyrrolobenzodiazepine carboxyamide vasopressin agonists
08/10/2000WO2000046227A1 Thienylbenzoylbenzazepines as vasopressin agonists
08/10/2000WO2000046225A2 Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
08/10/2000WO2000046224A2 Tricyclic pyridine n-oxides vasopressin agonists
08/10/2000WO2000046221A1 Sulfamato hydroxamic acid metalloprotease inhibitor
08/10/2000WO2000046220A1 Triazole and tetrazole derivatives, and their therapeutic use
08/10/2000WO2000046219A1 Alpha-azacyclomethyl quinoline derivatives for treating urinary incontinence
08/10/2000WO2000046215A1 Benzazepine derivatives as alpha-v integrin receptor antagonists
08/10/2000WO2000046214A1 Substituted 4-amino-2-aryltetrahydroquinazolines, their preparation, their use and pharmaceutical compositions comprising them
08/10/2000WO2000046210A2 New process for preparing pesticidal intermediates
08/10/2000WO2000046209A1 Pyrazolecarboxylic acid derivatives, their preparation, pharmaceutical compositions containing them
08/10/2000WO2000046208A1 Substituted pyrazole carboxylic acids used to combat anaemias
08/10/2000WO2000046204A1 Tetrahydro isoquino linealkanol derivatives and pharmaceutical compositions containing same
08/10/2000WO2000046199A2 Indole derivatives as anti-inflammation agents
08/10/2000WO2000046198A1 Anti-inflammatory indole derivatives
08/10/2000WO2000046197A1 Indole derivatives and their use as mcp-1 receptor antagonists
08/10/2000WO2000046196A1 Indole derivatives and their use as mcp-1 antagonists
08/10/2000WO2000046195A1 Anti-inflammatory indole derivatives
08/10/2000WO2000046191A1 O-thiocarbamoyl-aminoalkanol compounds, their pharmaceutically acceptable salts and process for preparing the same
08/10/2000WO2000046187A2 Antizyme modulators and their use
08/10/2000WO2000046183A1 N-substituted amino acids, antioxidant pharmaceutical compositions containing same and methods using same
08/10/2000WO2000045894A2 Use of pyrazole carboxamides
08/10/2000WO2000045873A1 Methods and compositions for use in perfusion applications
08/10/2000WO2000045852A1 Method of treating cancer by restoration of pp32 function
08/10/2000WO2000045851A2 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin
08/10/2000WO2000045849A2 Use of cationic lipids to generate anti-tumor immunity
08/10/2000WO2000045846A1 Pharmaceutical compositions containing nicotine or a ligand of nicotine receptors and a monamine oxydase inhibitor and their use for treating tobacco withdrawal symptoms
08/10/2000WO2000045845A2 Liposome composition and method for administration of a radiosensitizer
08/10/2000WO2000045837A1 Novel use within transplantation surgery
08/10/2000WO2000045829A1 Brassica extracts or sulforaphane in combination with resveratrol as antitumor agents
08/10/2000WO2000045828A1 Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition
08/10/2000WO2000045824A1 Preventive and therapeutic agents for arteriosclerosis
08/10/2000WO2000045822A1 Phosphocholine surfactants and their use
08/10/2000WO2000045821A1 Analgesic agent tetralgin and method for preparing the same
08/10/2000WO2000045820A1 Use of moxonidine for postmyocardial infarction treatment
08/10/2000WO2000045819A1 Use of cholesterol-lowering agent
08/10/2000WO2000045818A1 Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy
08/10/2000WO2000045817A1 Drug combinations comprising (e) -7 - [4 -(4 -fluorophenyl) -6 - isopropyl -2 - [methyl (methylsulfonyl) amino] pyrimidin -5 -yl] (3r,5s) -3,5 - dihydroxyhept -6 - enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4
08/10/2000WO2000045816A1 Calcilytic compounds
08/10/2000WO2000045815A1 Methods for alleviating discomfort of a hot flash and compositions therefor
08/10/2000WO2000045814A1 Methods and compositions to enhance white blood cell count
08/10/2000WO2000045813A1 Method for enhancement of delivery of thc by the administration of its prodrugs via the nasal route
08/10/2000WO2000045812A1 Anticonvulsant derivatives useful in treating autism
08/10/2000WO2000045811A1 Method for the prevention or reduction of cariovascular events associated with coronary intervention
08/10/2000WO2000045810A1 Method for the prevention or reduction of cardiovascular events associated with coronary intervention
08/10/2000WO2000045809A1 L-arginine based formulations for treating diseases and methods of using same
08/10/2000WO2000045808A1 Preparation for warts
08/10/2000WO2000045807A1 Pharmaceutical composition comprising a combination of dextro- and laevo- isomers of sotalol
08/10/2000WO2000045806A1 α1-ADRENERGIC RECEPTOR ANTAGONISTS
08/10/2000WO2000045805A2 Methods of inhibiting the hgf-met-upa-plasmin network with geldanamycin derivates
08/10/2000WO2000045804A2 Use of a polyanionic polysaccharide solution for the prevention of abscess formation
08/10/2000WO2000045803A2 Use of 5-aminosalicylates as antimicrobial agents
08/10/2000WO2000045802A2 Use of (alpha)-d-glucans for promoting cutaneous wound and ulcer healing
08/10/2000WO2000045801A2 Use of a nitrate vasodilator alone or in combination with capsaicin for the treatment of pain
08/10/2000WO2000045800A2 Immunosurpressive effects of pteridine derivatives
08/10/2000WO2000045799A2 Use of substituted isoxazol carboxylic acids and derivatives and novel substances
08/10/2000WO2000045795A2 Topical sprays comprising a film forming composition
08/10/2000WO2000045793A1 Ph independent extended release pharmaceutical formulation
08/10/2000WO2000045791A2 Method for controlling liposome size
08/10/2000WO2000045789A1 Anti-plaque emulsions and products containing same
08/10/2000WO2000045786A1 Cholesterol sulfate compositions for enhancement of stratum corneum function
08/10/2000WO2000045770A2 Compressed lecithin preparations
08/10/2000WO2000045769A2 Process for extracting polyphenolic antioxidants from purine-containing plants
08/10/2000WO2000045649A1 Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid
08/10/2000WO2000045648A1 Method of preparing microparticles of phytosterols or phytostanols
08/10/2000WO2000045634A1 Inositol derivatives for inhibiting superoxide anion production
08/10/2000WO2000033824A3 Bioflavonoids, anthocyanins and phenolic compounds from cherries for inhibiting inflammation
08/10/2000WO2000029008A3 Hiv-specific t-cell induction
08/10/2000WO2000028975A3 Improved chemical process and pharmaceutical formulation
08/10/2000WO2000027822A3 Tricyclic pyrazole derivatives
08/10/2000WO2000027424A3 Upregulation of endogenous prostaglandins to lower intraocular pressure
08/10/2000WO2000027372A8 Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents
08/10/2000WO2000026399A3 Method for the production of quercetin and isoquercetin derivatives
08/10/2000WO2000026239A3 $i(chlamydia) antigens and corresponding dna fragments and uses thereof
08/10/2000WO2000026185A3 Omeprazole solution and method of using same
08/10/2000WO2000024360A3 Preparation and use of solidified oils
08/10/2000WO2000021525A3 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent
08/10/2000WO2000015206A3 Tryptophanyl ester and their n-acyl derivatives for the prevention and treatment of diseases caused or exacerbated by oxidation processes
08/10/2000WO2000013706A8 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor
08/10/2000WO2000013691A9 3-deazaadenosine prevents atherosclerosis and graft vasculopathy
08/10/2000WO2000012509B1 Collections of compounds
08/10/2000WO2000010588A9 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs
08/10/2000WO2000010545A3 Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of nk-1 receptor antagonists for the treatment of chronic fatigue syndrome
08/10/2000WO2000010543A3 Medicament containing platinum complex compounds and the use thereof
08/10/2000WO2000004866A9 Preparation of thioarabinofuranosyl compounds and use thereof
08/10/2000WO1999066072A3 Methods for treating a neurological disease by determining bche genotype
08/10/2000WO1999063936A9 Novel therapeutic agents that modulate endothelin receptors
08/10/2000WO1999056666A8 The treatment of sexual dysfunction in certain patient groups
08/10/2000DE19906159A1 16-Hydroxyestratriene als selektiv wirksame Estrogene 16-hydroxyestratrienes as selective estrogens effective
08/10/2000DE19905278A1 Oxazolidinone und ihre Verwendung als antibakterielle Mittel Oxazolidinones and their use as antibacterial agents
08/10/2000DE19904801A1 Agent containing urea, sulfur and Calendula extract, useful for topical treatment of skin disorders, especially neurodermatitis
08/10/2000DE19904710A1 Substituierte 4-Amino-2-aryl-tetrahydrochinazoline, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate Substituted 4-amino-2-aryl-tetrahydroquinazolines, their preparation, their use and pharmaceutical compositions containing them
08/10/2000DE19904406A1 Substituierte Pyrazolcarbonsäuren Substituted pyrazole
08/10/2000DE19904397A1 Verwendung von Pyrazol-Carbonsäureamiden Use of pyrazole carboxamides
08/10/2000DE19904389A1 Verwendung von substituierten Isoxazolcarbonsäuren und Derivate und neue Stoffe Use of substituted Isoxazolcarbonsäuren and derivatives and new materials
08/10/2000DE19904365A1 Xantinol nicotinate medicament useful for treating circulatory disorders, joint affections and geriatric complaints includes procaine to reduce pain on injection
08/10/2000DE19904352C1 Lipide enthaltender Soja-Extrakt, Verfahren zu dessen Herstellung und pharmazeutische bzw. kosmetische Zusammensetzung sowie deren Verwendung zur Prävention oder Behandlung von trockener Haut Lipids containing soy extract, process for its preparation and to pharmaceutical or cosmetic composition and the use thereof for the prevention or treatment of dry skin
08/10/2000DE19903398A1 Verwendung von Thiadiazolderivaten zur prophylaktischen und therapeutischen Behandlung von Infektionen The use of thiadiazole derivatives for the prophylactic and therapeutic treatment of infections
08/10/2000DE19903087A1 Behandlung von erektilen Dysfunktionen mit C-Typ Natriuretischem Polypeptid (CNP) als Monotherapie oder in Kombination mit Phosphodiesterasehemmern Treatment of erectile dysfunction with C-type natriuretic polypeptide (CNP) as monotherapy or in combination with phosphodiesterase inhibitors
1 ... 6264 6265 6266 6267 6268 6269 6270 6271 6272 6273 6274 6275 6276 6277 6278 6279 6280 6281 6282 6283 6284 ... 7860